ARTICLE | Clinical News
Posidur bupivacaine regulatory update
November 24, 2014 8:00 AM UTC
Durect said FDA indicated that only 1 additional soft tissue clinical trial of Posidur bupivacaine would be acceptable if the company pursued an initial indication of soft tissue postoperative analges...